Traci S.

Traci S. is an accomplished medical professional currently serving as the Associate Vice President of US Donanemab Medical Affairs at Eli Lilly and Company. Traci has held significant roles in the medical field, including as Executive Director of Gene Therapy Clinical Development at PTC Therapeutics, and as Field Medical Director, Scientific Lead at Axovant Sciences, focusing on Alzheimer's disease. Prior to these positions, Traci was an instructor at Beth Israel Deaconess Medical Center and held various roles as an attending neurologist, where they contributed to clinical research in multiple sclerosis and chronic pain. Traci earned an MD from SUNY Health Science Center at Brooklyn and completed a fellowship in Clinical Neurophysiology at Brown University.